122 related articles for article (PubMed ID: 8571068)
1. [Lithium clearance in polycystic kidney disease].
Merta M; Tesar V; Zabka J; Zima T
Sb Lek; 1994; 95(1):19-23. PubMed ID: 8571068
[TBL] [Abstract][Full Text] [Related]
2. [Plasma volume in polycystic kidney disease].
Merta M; Chábová V; Tesar V; Zima T; Mokrejsová M; Zabka J; Bakos K
Sb Lek; 1994; 95(1):15-8. PubMed ID: 8571067
[TBL] [Abstract][Full Text] [Related]
3. Renal and cardiac effects of antihypertensive treatment with ramipril vs metoprolol in autosomal dominant polycystic kidney disease.
Zeltner R; Poliak R; Stiasny B; Schmieder RE; Schulze BD
Nephrol Dial Transplant; 2008 Feb; 23(2):573-9. PubMed ID: 17984104
[TBL] [Abstract][Full Text] [Related]
4. [Regulation of natriuresis in diabetic nephropathy].
Późniak J
Ann Acad Med Stetin; 2000; 46():241-52. PubMed ID: 11712308
[TBL] [Abstract][Full Text] [Related]
5. Impact of posttransplant diabetes mellitus on graft function in autosomal dominant polycystic kidney disease patients after kidney transplantation.
Pietrzak-Nowacka M; Safranow K; Dziewanowski K; Debska-Slizień A; Głyda M; Gołembiewska E; Jankowska M; Nowosiad M; Rutkowski B; Ciechanowski K
Ann Acad Med Stetin; 2008; 54(1):41-8. PubMed ID: 19127808
[TBL] [Abstract][Full Text] [Related]
6. Abnormal distal tubular sodium reabsorption during dopamine infusion in patients with essential hypertension evaluated by the lithium clearance methods.
Nielsen CB; Pedersen EB
Clin Nephrol; 1997 May; 47(5):304-9. PubMed ID: 9181277
[TBL] [Abstract][Full Text] [Related]
7. Lithium clearance in the evaluation of segmental renal tubular reabsorption of sodium and water in diabetes mellitus.
Skøtt P
Dan Med Bull; 1994 Feb; 41(1):23-37. PubMed ID: 8187564
[TBL] [Abstract][Full Text] [Related]
8. Cimetidine administration and tubular creatinine secretion in patients with compensated cirrhosis.
Sansoè G; Ferrari A; Castellana CN; Bonardi L; Villa E; Manenti F
Clin Sci (Lond); 2002 Jan; 102(1):91-8. PubMed ID: 11749665
[TBL] [Abstract][Full Text] [Related]
9. Pressure-dependent distal tubular action of atrial natriuretic peptide in healthy humans.
Eiskjaer H; Nielsen CB; Pedersen EB
J Hypertens; 1996 Jan; 14(1):99-106. PubMed ID: 12013501
[TBL] [Abstract][Full Text] [Related]
10. Unchanged lithium clearance during acute amiloride treatment in sodium-depleted man.
Bruun NE; Skøtt P; Lønborg-Jensen H; Giese J
Scand J Clin Lab Invest; 1989 May; 49(3):259-63. PubMed ID: 2500701
[TBL] [Abstract][Full Text] [Related]
11. Pulse wave reflection is amplified in normotensive patients with autosomal-dominant polycystic kidney disease and normal renal function.
Borresen ML; Wang D; Strandgaard S
Am J Nephrol; 2007; 27(3):240-6. PubMed ID: 17389784
[TBL] [Abstract][Full Text] [Related]
12. Influence of VEGF polymorphism on progression of autosomal dominant polycystic kidney disease.
Reiterová J; Obeidová H; Lenícek M; Stekrová J; Merta M; Maixnerová D; Vítek L; Viklický O; Tesar V
Kidney Blood Press Res; 2008; 31(6):398-403. PubMed ID: 19060482
[TBL] [Abstract][Full Text] [Related]
13. [Blood pressure, functional and morphological study of kidneys in children with autosomal dominant polycystic kidney disease].
Seeman T; Vondrichová H; Strízová J; Sikut M; Janda J; Schärer K
Cas Lek Cesk; 1999 Mar; 138(6):178-84. PubMed ID: 10510532
[TBL] [Abstract][Full Text] [Related]
14. Autosomal-dominant polycystic kidney disease and kidney transplantation: experience of a single center.
Gonçalves S; Guerra J; Santana A; Abreu F; Mil-Homens C; Gomes da Costa A
Transplant Proc; 2009 Apr; 41(3):887-90. PubMed ID: 19376380
[TBL] [Abstract][Full Text] [Related]
15. Renal response to prostaglandin E1 infusion in polycystic kidney disease versus non-polycystic renal disease.
Uemasu J; Munemura C; Fujihara M; Kawasaki H
Clin Nephrol; 1995 Oct; 44(4):225-30. PubMed ID: 8575121
[TBL] [Abstract][Full Text] [Related]
16. [Renal sodium handling in ouabain-hypertensive rats].
Ge H; Ren YP; Lui ZR
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2005 Aug; 27(4):461-5. PubMed ID: 16178440
[TBL] [Abstract][Full Text] [Related]
17. Carotid vascular remodelling in patients with autosomal dominant polycystic kidney disease.
Rong S; Jin X; Ye C; Chen J; Mei C
Nephrology (Carlton); 2009 Feb; 14(1):113-7. PubMed ID: 19335845
[TBL] [Abstract][Full Text] [Related]
18. Exercise capacity in polycystic kidney disease.
Reinecke NL; Cunha TM; Heilberg IP; Higa EM; Nishiura JL; Neder JA; Almeida WS; Schor N
Am J Kidney Dis; 2014 Aug; 64(2):239-46. PubMed ID: 24787761
[TBL] [Abstract][Full Text] [Related]
19. [Epidemiologic data, clinical and prognostic features of autosomal dominant polycystic kidney disease in a French region].
Simon P; Le Goff JY; Ang KS; Charasse C; Le Cacheux P; Cam G
Nephrologie; 1996; 17(2):123-30. PubMed ID: 8838759
[TBL] [Abstract][Full Text] [Related]
20. Characteristics of hypertension in young adults with autosomal dominant polycystic kidney disease compared with the general U.S. population.
Kelleher CL; McFann KK; Johnson AM; Schrier RW
Am J Hypertens; 2004 Nov; 17(11 Pt 1):1029-34. PubMed ID: 15533729
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
